外企争相在华深化科研布局

Group 1 - Sony (China) Co., Ltd. has made significant progress in its life sciences business with the production of the first locally manufactured spectral cell analyzer in China, which has been delivered to Jinzhou Medical University in Liaoning Province [1] - This development marks the first equipment produced under Sony's localization plan announced in early April, reflecting the trend of foreign companies enhancing their manufacturing and delivery capabilities in China [1] - The localization of core products by foreign enterprises in China is indicative of a broader shift towards "Made in China" evolving into "R&D for China," showcasing the country's growing importance as a global R&D base [1] Group 2 - An increasing number of foreign enterprises are establishing a "manufacturing base + R&D center" model in China to enhance local service capabilities, providing advanced equipment and customized solutions, which reflects their confidence in China's economic prospects [2] - China's commitment to high-quality development, including green, digital, and intelligent transformations, creates optimal conditions for foreign enterprises, offering new cooperation opportunities [2] - The Chinese government is expanding high-level opening-up and optimizing the business environment, which supports foreign enterprises' development in the country [2] Group 3 - The atmosphere for foreign enterprises to innovate and invest in China is growing, with increased efforts in product development and R&D investments, which invigorates the Chinese market's innovation vitality [3]